Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Practice-changing evidence requires confirmation, preferably in multi-institutional clinical trials. The collection of tissue within such trials has enabled biomarker studies and evaluation of companion diagnostic tests. Tissue microarrays (TMAs) have become a standard approach in many cooperative o...

Full description

Saved in:
Bibliographic Details
Main Authors: Rimm, David L., Nielsen, Torsten O., Jewell, Scott D., Rohrer, Daniel C., Broadwater, Gloria, Waldman, Frederic, Mitchell, Kisha A., Singh, Baljit, Tsongalis, Gregory J., Frankel, Wendy L., Magliocco, Anthony M., Lara, Jonathan F., Hsi, Eric D., Bleiweiss, Ira J., Badve, Sunil S., Chen, Beiyun, Ravdin, Peter M., Schilsky, Richard L., Thor, Ann, Berry, Donald A.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2011
Subjects:
Special Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107745/
https://ncbi.nlm.nih.gov/pubmed/21519016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.2023
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items